William H. Crown, Ph.D., is Chief Scientific Officer of Optum Labs. In this role, he is responsible for both the internal and external research activities of the Labs. Dr. Crown came to Optum after spending more than a decade at Thompson Reuters Medstat, where he was Vice President of Outcomes Research and Econometrics in the Research and Pharmaceutical division. From 1982-1995, Dr. Crown was a faculty member of the Florence Heller Graduate School, Brandeis University, where he taught graduate courses in statistics and conducted research on the economics of aging and long-term care policy. He was Director of Policy Studies in the Policy Center on Aging from 1989-1995, and Faculty Chair of the Heller School from 1992-1993. He received his doctorate degree in urban and regional studies from the Massachusetts Institute of Technology, and a master of arts in economics from Boston University. The author of two books and co-author of two others, Dr. Crown has published more than 100 peer-reviewed journal articles, book chapters, and other scholarly papers. Known for his early application of sample selection bias models in the pharmaceutical outcomes research literature, he is a frequent speaker on pharmaceutical economics and econometric methodology at professional meetings and conferences. In addition to his CSO role within Optum Labs, Dr. Crown is Affiliate Faculty, Mongon Institute for Health Policy, Harvard University, as well as Chair of the OptumInsight Fellows Program and a UHG Innovation Champion. Dr. Crown is also 2013-2014 President of the International Society of Pharmacoeconomics and Outcomes Research.